Joao Pedro Ferreira Selected Research

Therapeutics

11/2023	Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF.
2/2022	Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.
1/2022	Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.
10/2021	Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joao Pedro Ferreira Research Topics

Disease

13	Heart Failure 11/2023 - 12/2020
2	Body Weight (Weight, Body) 08/2023 - 01/2021
1	Coronary Disease (Coronary Heart Disease) 11/2023
1	Ischemic Stroke 11/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Albuminuria 01/2023
1	Atherosclerosis 01/2023
1	Inflammation (Inflammations) 01/2023
1	Hypotension (Low Blood Pressure) 01/2022
1	Disease Progression 01/2021
1	Atrial Fibrillation 01/2021

Drug/Important Bio-Agent (IBA)

9	empagliflozinIBA 08/2023 - 12/2020
3	Sodium-Glucose Transport ProteinsIBA 02/2022 - 01/2021
2	pro-brain natriuretic peptide (1-76)IBA 08/2023 - 01/2023
2	DiureticsIBA 08/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	Troponin T (Troponin T1)IBA 01/2023 - 01/2021
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 01/2023
2	Natriuretic PeptidesIBA 01/2021 - 01/2021
1	RivaroxabanIBA 11/2023
1	InterleukinsIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023
1	SodiumIBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	SymportersIBA 12/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2021
1	Neprilysin (Neutral Endopeptidase)IBA 11/2021
1	TroponinIBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021

Therapy/Procedure

4	Therapeutics 11/2023 - 10/2021
1	Critical Care (Surgical Intensive Care) 10/2021